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Abstract Ischemia/reperfusion induces nuclear factor KB (NF-
KB) and AP-1 in rat hearts after 15 min of ischemia followed by 
reperfusion (R) for various periods of time (15 and 30 min, 1, 2, 
3, 6,12, and 24 h). Low levels of NF-KB and no signal for AP-1 
were detected in shams and in non-ischemic tissue distant from 
the ischemic zone. In postischemic tissue, NF-KB levels increased 
biphasically with peak levels at 15 min and again at 3 h R. 
Immunoblotting showed minimal NF-KB p50 subunit at all times, 
with changes in p65 similar to EMSA results. Northern blots 
showed low p50 and increased p65 expression levels at both 2 and 
3 h R. By contrast, AP-1 increased monophasically, with peak 
levels at 15 min R, which dropped steadily thereafter. These 
results indicate that NF-KB and AP-1 are differentially regulated 
during reperfusion, which may be a control mechanism for gene 
expression in reperfused myocardium. 
Key words: Reperfusion injury; Activation protein 1; 
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1. Introduction 
In the past decade it has been established that free radicals 
— reactive oxygen intermediates (ROI) and NO — play a 
causal role in myocardial reperfusion injury, resulting in a 
condition characterized by myocardial dysfunction [1,2]. 
ROI have been shown in various in vitro systems to be im-
portant second messengers in the activation of nuclear factor 
KB ( N F - K B ) [3-5]. N F - K B , detected ubiquitously, is an induc-
ible multisubunit DNA-binding protein that has been impli-
cated in the transcriptional regulation of many genes involved 
in inflammation, immune responses, and acute phase reactions 
[3-5]. It consists of a DNA-binding subunit of 50 kDa that 
usually is found complexed with a second subunit of 65 kDa. 
In the cytosol, N F - K B exists as an inactive form because of its 
association with an inhibitory molecule, I-KB. Upon activa-
tion N F - K B dissociates from I-KB, and the p50-p65 hetero-
dimer translocates to the nucleus, binds to decameric consen-
sus sequences in the promoter/enhancer regions of the target 
genes, and induces their expression. 
AP-1 is another well-characterized eukaryotic transcription 
factor that is highly regulated by the redox status of the cell 
[6,7]. It is composed of various subunits (jun, fos, and Fra) as 
dimers, which recognize with different affinities the AP-1 
DNA-binding site. Though the mechanism of ROI induction 
of AP-1 is not clear, alteration of cell thiol redox status has 
been shown to induce c-fos and c-jun expression, and phos-
phorylation of jun proteins. Many factors including ionizing 
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radiation, cytokines, and growth factors lead to AP-1 activa-
tion. Similar to N F - K B , activation of AP-1 induces expression 
of a variety of genes whose protein products may either pro-
tect the cells from, or make the cells more susceptible to, 
oxidative stress. Although we and others have shown in-
creased proinflammatory cytokine (IL-lß, IL-6, and TNF-oc) 
as well as iNOS expression in postischemic myocardium [8,9], 
the mechanisms by which these inflammatory molecules are 
up-regulated is not known. Since ROI are known to activate 
N F - K B and AP-1, and because these cytokines contain AP-1 
and N F - K B response elements [10,11], it is reasonable to pos-
tulate that in ischemia/reperfusion (I/R), where ROI are 
known to be elevated [1,2], AP-1 and N F - K B may play a 
role. The purpose of this study was to examine the levels of 
AP-1 and N F - K B , and the expression of the major subunits of 
N F - K B (p50 and p65) at various times after a brief ischemic 
episode in reperfused myocardium. 
2. Materials and methods 
2.1. Animals 
WKY rats (200 g) obtained from Charles River Laboratories were 
used in the present studies. Before their use in the experiments, ani-
mals were housed at least for 4 days in a climate- and light-controlled 
environment at the Laboratory Animal Care facility at the University 
of Texas Health Science Center, San Antonio. The animals were an-
esthetized with a rat cocktail, containing 44 mg/kg ketamine, 1 mg/kg 
acepromazine, and 8.5 mg/kg xylazine, intubated, and placed on a 
small animal ventilator. The chest was opened by midline sternotomy, 
and a 6-0 silk ligature was passed around the LAD coronary artery 
and through a snare. In the I/R group the snare was tightened until 
coronary occlusion occurred. This was readily discernible by the de-
velopment of a dusky, bulging region of myocardium. Careful note 
was made of anatomic landmarks of this region. After 15 min the 
snare was released, allowing reperfusion of the ischemic zone. Animals 
(4/group) were randomly assigned to different durations of reperfu-
sion (R), either 15 min, 30 min, l, 2, 3, 6, 12, or 24 h. In sham-
operated animals the same procedure was followed, but the snare 
was not tightened. After the experimental period the heart was rapidly 
excised and rinsed in ice-cold physiological saline. The right ventricle 
and atria were trimmed away, and the LV divided into ischemic and 
non-ischemic zones on the basis of the previously defined landmarks. 
The tissue was snap frozen in liquid N2, and stored for not more than 
3 days at —82°C before extracting total RNA and protein. 
2.2. Electrophoretic mobility shift assay 
Protein extracts were prepared from frozen hearts using a buffer 
containing 20 mM Hepes, pH 7.8, 300 mM NaCl, 0.4 mM EDTA, 0.5 
mM DTT, 25% glycerol, and 0.5 mM PMSF, spun at 14000 rpm for 
10 min at 4°C. Protein concentration was determined by BCA protein 
assay reagent (Pierce, Rockford, IL). The electrophoretic mobility 
shift assay (EMSA) was performed essentially as described by Dent 
and Latchman [12] with some minor modifications. Briefly, a double-
stranded oligonucleotide (NF-KB, 5'-AGT TGA GGG GAC TTT 
CCC AGG C-3'; AP-1, 5'-CGC TTG ATG ACT CAG CCG 
GAA-3'; Santa Cruz Biotechnology, Inc., Santa Cruz, CA) contain-
ing a tandem repeat of the consensus sequences of -GGGG-
ACTTTCC- (NF-KB) or -TGACTCA- (AP-1) was end-labeled with 
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[y-32P]ATP (Amersham, Arlington Heights, IL) and T4 polynucleotide 
kinase (Promega, Madison, WI). The binding reaction was performed 
by mixing 20 ug of protein extract, 2 ug of poly (dl-dC) (Pharmacia, 
Nutley, NJ) and 111 TBq/mmol [y-32P]ATP-labeled oligo probe in 
binding buffer (20 mM Hepes (pH 7.9), 1 mM MgCl2, 4% Ficoll, 
0.5 mM DTT, KC1 to a final concentration of 50 mM) and then 
incubated for 40 min on ice. For the competition assay the protein 
extract (20 ug) was preincubated with homologous unlabeled oligo-
nucleotide for 5 min on ice, followed by the addition of labeled probe. 
All the samples were then electrophoresed at 150 V through 4% poly-
acrylamide gel (0.25 XTBE). The gels were dried and autoradio-
graphed with intensifying screens, and the autoradiographic bands 
were semi-quantified by videoimage analysis. A corresponding mutant 
oligo ( N F - K B , 5'-AGT TGA GGC GAC TTT CCC AGG C-3'; AP-
1, 5'-CGC TTG ATG ACT TGG CCG GAA-3'; Santa Cruz Bio-
technology, Inc.) was used as a control. 
Antibodies and Western blot analysis: N F - K B subunit-specific poly-
clonal antibodies (p50 and p65) were from Santa Cruz Biotechnology, 
Inc. Specificity of these antibodies was verified by incubating them 
with their respective antigens for 1 h at 37°C followed by 14 h at 4°C. 
Equal amounts of homogenates from ischemic and non-ischemic 
heart tissue were subjected to Tris-glycine 16.5% SDS-PAGE, and 
electroblotted onto nitrocellulose membrane (S&S, Inc., Keene, NH) 
[13,14]. The membranes were then incubated with 10% normal goat 
serum (pre-immune) to block for non-specificity followed by incuba-
tion at 23°C for 1 h and 18 h at 4°C with respective primary antibody 
(after determining the optimal concentrations of antibodies). The 
membranes were then washed with a buffer containing 20 mM Tris 
(pH 7.5), 500 mM NaCl, and 0.05% (v/v) Tween-20, incubated with 
< 
Fig. 1. Analysis of N F - K B levels by EMSA. EMSA was performed 
with 20 ug °f heart homogenate and 32P-labeled double-stranded 
N F - K B consensus sequence and electrophoresed through 4% poly-
acrylamide gel. The autoradiographic exposure time was 8 h at 
—80°C with intensifying screens, and the autoradiogram of the na-
tive gel is shown. Each lane represents protein homogenate from an 
individual animal. <, Complexes tested for specific binding; <=, un-
incorporated labeled probe. Non-ischemic zone: myocardium adja-
cent to ischemic zone at the indicated periods of reperfusion. Sham-
operated: control. Competed: N F - K B : labeled NF-KB+250-fold ex-
cess unlabeled N F - K B (consensus sequence) oligo+20 (ig of homoge-
nate from postischemic portion of myocardium at 15 min R. mutant 
N F - K B : labeled NF-KB+250-fold excess unlabeled mutant N F - K B 
oligo+20 ug of homogenate from postischemic portion of myocar-
dium at 15 min R. 
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Fig. 2. Effect of various periods of reperfusion following a single 
episode of ischemia on N F - K B levels. EMSA was performed essen-
tially as described in Section 2. Each lane represents protein homog-
enate from an individual animal. The autoradiographic exposure 
time was 8 h at — 80°C with intensifying screens, and the autoradio-
gram of the native gel is shown. No protein: all the components in 
the reaction mixture including labeled N F - K B are present except the 
protein homogenate. Competed N F - K B : Competed with 250-fold ex-
cess unlabeled N F - K B and protein homogenate from sample 1 of 15 
min R. 
the second antibody (goat anti-rabbit) for 2 h at 23°C, washed, and 
incubated at 23°C for 2 h with [125I]protein A (0.33 uCi/ml; Amer-
sham). Autoradiography was performed by exposing the blots to Ko-
dak XAR-5 film at —80°C with intensifying screens. The intensity of 
autoradiographic bands was semi-quantified as described above. 
RNA extraction and Northern blot analysis. Total RNA was ex-
tracted from frozen heart tissue using acid-guanidium isothiocyanate-
phenol-chloroform [15], and equal amounts (30 ug) of RNA were 
denatured in 2.2 M formaldehyde, size fractionated on 0.8% agarose 
gels containing 0.5 ug/ml ethidium bromide to check RNA integrity 
and loading equivalency, and electroblotted at 4°C onto a nitrocellu-
lose membrane (Schleicher and Schuell, Inc., Keene, NH) in 0.025 M 
phosphate buffer, pH 6.5 [13,14]. RNA was UV cross-linked (Strata-
linker 2400, Stratagene, La Jolla, CA) to the membrane. The blot was 
prehybridized for 4 h at 42°C in a prehybridization buffer that con-
tained 50% formamide, 0.1% SDS, 5XSSC, 2.5xDenhardt's, 250 ug/ 
ml denatured sonicated salmon sperm DNA (Stratagene), 50 mM 
Na 2P0 4 , pH 6.5. The blots were then hybridized at 42°C for 16 h 
with 32P-labeled probes (6X105 cpm/ml), washed twice at 23°C in 
6xSSC/0.5% SDS, twice at 37°C in lxSSC/0.5% SDS, and once at 
57°C in 0.1XSSC/0.5% SDS. All blots were then exposed at -80°C to 
Kodak XAR-5 film with Kodak intensifying screens, and the intensity 
of the autoradiographic bands was semi-quantified by videoimage 
analysis [13,14]. The same membrane was reprobed after stripping 
off its previous label. 
The N F - K B p50 and p65 cDNA probes (a kind gift from Dr. Mar-
tin L. Scott, MIT, Cambridge, MA) [16,17] were labeled with [a-
32P]dCTP (3000 Ci/mmol; Amersham) to a specific activity of 0.6-
1.0 X109 cpm/|xg, using random hexanucleotide primers (Boehringer 
Mannheim, Indianapolis, IN). In order to assess loading equivalency 
and RNA integrity, 28S rRNA (h28S rRNA; 40mer single-stranded 
synthetic oligonucleotide; Oncogene Science, Inc., Uniondale, NY) 
was used as an internal control, and was 5'-end labeled with [y-
32 P]ATP (Amersham, Arlington Heights, IL) and T4 polynucleotide 
kinase (Gibco BRL, Grand Island, NY). mRNA sizes were deter-
mined in relation to the relative mobility of 28S and 18S rRNA, 
and an mRNA ladder (0.24-9.5 kb; Gibco BRL). 
Statistical analysis. The data (mean ± SEM) for levels of expression 
of individual protein (EMSA and Western blot) and mRNA were 
subjected to analysis of variance with post hoc Dunnett's 1-tailed t-
tests ( N F - K B EMSA, Immunoblotting and Northern), and 1-sample 
Student's i-test for significance (AP-1 EMSA, as AP-1 was not de-
tected in the controls). P < 0.05 was considered significant. 
3. Results 
3.1. NF-KB levels 
Fig. 1 shows N F - K B levels in the myocardium from controls 
(sham-operated and non-ischemic port ion adjacent to is-
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but at low levels, with levels of p65 which were little higher 
than p50. In postischemic myocardium, low and consistent 
levels of p50 were detected at all times tested. In contrast, 
p65 mRNA levels increased at 1 h R (densitometry: 1.4-
fold, P<0.05) , peaked at 2 h R (2.9-fold: P<0.001), re-
mained elevated at 3 h R (1.3-fold: P<0.05) and declined 
gradually thereafter, and remained low until 24 h R (Fig. 4). 
Fig. 3. NF-KB p50 and p65 subunit protein levels in control (sham-
operated) and postischemic myocardium for (n=4). Equal amounts 
of protein per lane were electrophoresed using Tris-glycine 16.5% 
SDS-PAGE. The separated proteins were electroblotted onto nitro-
cellulose. After blocking with 10% normal goat serum, the mem-
brane was sequentially incubated with the primary, secondary and 
125I-Protein A. Autoradiographic exposure time was 4 days for both 
the subunits. Pre-stained protein molecular mass standards (Bio-
Rad) were shown on the left. Arrow indicates the relative position 
of protein detected by the respective antibody. 
chemic zone). Low and consistent levels of N F - K B were de-
tected in normal myocardium (sham-operated) at steady state, 
and no detectable change was observed in the non-ischemic 
tissue. Specificity of the signal was verified in a competition 
assay wherein the signal detected by labeled N F - K B was abol-
ished when the protein homogenate was preincubated with 
excess unlabeled N F - K B oligo before the addition of labeled 
N F - K B . When a mutant oligo was used for the competition, 
there was no interference with the signal generated by labeled 
N F - K B . Furthermore, when labeled mutant N F - K B was used 
in the EMSA, no signal was detected (data not shown). 
Fig. 2 shows changes in N F - K B levels in the postischemic 
myocardium. Significantly higher levels of N F - K B were de-
tected at 15 min R in all 4 animals (densitometry: 3-fold; 
P< 0.0001), remained high in two out of four animals at 30 
min R (2-fold, not significant), and then fell to steady state at 
1 h R. Again at 3 h R, the levels rose significantly higher 
(4.56-fold; P< 0.0001), and were 1.5-fold higher than the lev-
els at 15 min R (P< 0.005). The levels remained high at 6 h 
R (3-fold; P< 0.005), and fell thereafter and remained low 
until 24 h R, indicating a biphasic regulation of N F - K B in 
postischemic myocardium. 
3.4. AP-1 levels 
Fig. 5 shows changes in AP-1 levels in control (non-is-
chemic tissue adjacent to ischemic zone and sham-operated) 
and in the postischemic myocardium. No signal was detected 
in either control. However, signal was readily detected in post-
ischemic myocardium, with peak levels at 15 min R 
(P< 0.001; Fig. 5B). Though the levels declined gradually, 
they were still high at 30 min, 1 h, 2 h, and 3 h R, and by 
24 h R very weak signal for AP-1 was detected. Preincubation 
of protein homogenate with excess unlabeled AP-1 consensus 
oligo abolished specific signals obtained by labeled AP-1, 
demonstrating the specificity of signals (Fig. 5A). Further, 
when competed with mutant AP-1 oligo, there was no inter-
ference with the signal generated by labeled AP-1. Further-
more, when labeled mutant AP-1 was used in the EMSA, no 
signal was detected (data not shown). 
4. Discussion 
The results of our experiments show for the first time that 
there is a biphasic regulation of N F - K B in postischemic myo-
cardium. Immunoblotting and mRNA analyses revealed in-
creased levels of N F - K B p65 subunit, but low and consistent 
levels of p50 subunit. In addition, increased levels of AP-1 
were detected, but in a monophasic manner. These results 
3.2. NF-KB p50 and p65 protein levels 
Because variation in N F - K B levels was not detected in either 
sham-operated animals or in non-ischemic tissue adjacent to 
the ischemic zone, and between these two groups (Fig. 3), we 
used myocardium from sham-operated animals as controls for 
Western blotting experiments. Low and consistent levels of 
N F - K B p50 subunit were observed in both the controls and 
in postischemic myocardium at all time periods tested (Fig. 3). 
In the case of p65 subunit, the levels were higher at 15 min R 
(densitometry: 5-fold; P< 0.0001), and decreased gradually 
thereafter (30 min R, 3-fold; P<0.025; 1 h R, 2-fold, 
P< 0.001; 2 h R, 2-fold, P< 0.005) (Fig. 3). Again at 3 h 
R, the levels raised significantly higher (7-fold: P< 0.0001; 
1-fold: P<0 .01 vs. levels at 15 min R) and remained high 
(P< 0.0001) at 6 h (5-fold), 12 h (3-fold), and fell thereafter at 
24 h R (2-fold: P<0.001). 
3.3. NF-KB p50, and p65 mRNA levels 
Fig. 4 shows changes in N F - K B subunit mRNA levels in 
control (sham-operated) and in the postischemic myocardium. 
In control animals, both p50 and p65 mRNA was detected 
Fig. 4. Expression of NF-KB p50 and p65 subunit mRNA in the 
control and postischemic myocardium. Thirty micrograms of total 
RNA per lane was electrophoresed, electroblotted onto nitrocellu-
lose, and fixed by UV irradiation. The blot was reprobed after strip-
ping off the previous probe. mRNA size was determined in compar-
ison to the relative mobility of 28S and 18S rRNA and to that of 
the mRNA ladder (0.2-9.5 kb). 28S rRNA was used as an internal 
control and indicates equal levels of RNA loading in all lanes of 
the gel. The autoradiographic time was 4 days for p50 and p65, and 
14 h for 28S rRNA. Even after 8 days of autoradiographic expo-
sure, no signal was detected in lanes that did not have detectable 
levels of mRNA. 
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Fig. 5. (A) Levels of AP-1 in non-ischemic tissue adjacent to is-
chemic zone (internal control) detected by EMSA. EMSA was per-
formed essentially as described in the legend to Fig. 1. After incuba-
tion of 20 |ig of heart homogenate with 32P-labeled double-stranded 
AP-1 consensus sequence, it was electrophoresed through 4% poly-
acrylamide gel. The autoradiographic exposure time was 8 h at 
—80°C with intensifying screens, and the autoradiogram of the na-
tive gel is shown. Each lane represents protein homogenate from an 
individual animal. <-, Complexes tested for specific binding; <=, 
unincorporated labeled probe. Competed: (1) AP-1: labeled AP-
1+250-fold excess unlabeled AP-1 (consensus sequence) oligo+20 ug 
of homogenate from postischemic myocardium at 15 min R. (2) 
Mutant AP-1: Labeled AP-1 +250-fold excess unlabeled mutant AP-
1 oligo+20 |Xg of homogenate from postischemic myocardium at 15 
min R. (B) Levels of AP-1 in postischemic myocardium at indicated 
periods of reperfusion. Control: sham-operated. 
indicate that N F - K B p65 as opposed to p50 may play a pre-
dominant role, and AP-1 and N F - K B are differentially regu-
lated in myocardium during ischemia/reperfusion. 
We found a biphasic regulation of N F - K B , with increased 
levels at an early time point (15 min), and again at 3 h R. It is 
likely that increased levels of ROI present in the tissue imme-
diately after reperfusion activated the preexisting N F - K B 
which was present in the cytoplasm, resulting in increased 
N F - K B at 15 min R. Given the transient nature of ROI eleva-
tion, however, it is difficult to attribute the secondary rise in 
N F - K B at 3 h R to this mechanism. The timing of this event 
suggests it may have resulted from synthesis of new protein, 
induced by the I/R sequence. In view of the known presence 
of proinflammatory cytokines in the tissue under these cir-
cumstances (possibly induced by activated N F - K B early in 
reperfusion), it is reasonable to speculate that they may 
have further induced ROI production, and provided the stim-
ulus for increased N F - K B at 3 h R. Prior work has shown that 
many N F - K B activators induce oxidative stress: cells treated 
with TNF-oc, IL-1, or y-irradiation all had increased produc-
tion of ROIs [18,19]. While the precise mechanisms by which 
these cytokines increase ROI production is not known, 
evidence suggests that in the case of TNF-oc, mitochondrial 
production of ROI through an alteration in the mitochondrial 
electron flow occurs [20]. Regardless of their source, presence 
of ROI likely leads to activation of N F - K B . 
A second key observation of our study is the detection of 
increased levels of p65, but low and consistent levels of p50 in 
the postischemic myocardium. Further, mRNA analysis re-
vealed similar results with low and consistent levels of p50, 
and an increase in p65 with peak levels at 2 h reperfusion. The 
levels dropped steadily, and by 24 h reperfusion, the levels 
were similar to that observed at basal conditions. Induction 
of N F - K B at very early times is reported to be at the post-
translational level, and this may underlie the initial peak we 
observed in N F - K B , resulting from activation of existing p50 
and p65 or p65 homodimers. The subsequent increase ob-
served at 3 h reperfusion, coincident with presence of 
mRNA, is suggestive of increased p65 transcription and trans-
lation. Prior studies have shown that p50 is a DNA-binding 
subunit, and p65 is an 1-KB binding subunit. Following ap-
propriate stimuli, I-KB dissociates from p65 and existing p50-
p65 heterodimers translocate to the nucleus [3-5]. Recent 
studes have, however, shown that in some instances p65 can 
act as a potential transcriptional activator of KB enhancer-
containing promoters [21,22] in the absence of association 
with p50. In addition, p65 has been shown to form hetero-
dimers with c-Rel before binding to DNA [23]. Because the 
role of other subunits is not known, additional studies will be 
required to clearly establish the function and regulation of p65 
in the pathophysiology of myocardial reperfusion injury. 
The intracellular events which lead to the activation of NF-
KB (i.e. dissociation of I-KB) are complex and involve phos-
phorylation and proteolytic reactions that are in general con-
trolled by the redox status of the cell [23]. Immediately after 
the initiation of reperfusion from ischemia, the myocardium is 
exposed to unphysiologically high levels of ROI [1,2], and 
consequent oxidative stress, which activates N F - K B . Prior 
studies have shown that activation of N F - K B in various 
immune cells results from the addition of oxidants such as 
H2O2, which leads to release of I-KB from N F - K B heterodimer 
in the cytoplasm leading to p50-p65 translocation to the 
nucleus [24]. 
We and others have shown that there is induction of proin-
flammatory cytokines such as IL-ß, IL-6 and TNF-oc in the 
postischemic myocardium [8,9]. Because these cytokines con-
tain KB response elements in their promoter/enhancer regions, 
it is reasonable to speculate that increased ROI produced 
during I/R might have activated N F - K B , which in turn might 
have induced, through various signaling pathways, mRNA 
expression of these cytokines. It is now well established that 
in addition to ROI, cardiac tissue generates NO in response to 
soluble inflammatory mediators, through the delayed expres-
sion of iNOS [25]. The 5'-flanking region of iNOS is quite 
complex and contains consensus sequences for several tran-
scription factors, some in multiple copies, including two cop-
ies of the N F - K B response element, and two copies of TNF 
response elements. This indicates that once it is activated, NF-
KB can translocate to the nucleus, and bind to the iNOS 
promoter [26]. Of note, Goldring et al. have demonstrated 
that by reducing NF-KB/Rel activity through competitive 
binding (of phosphorothioate-modified oligo containing three 
copies of N F - K B consensus sequences), a 50% reduction in 
NO output and a reduction in the quantity of iNOS protein 
was achieved, implying that activated N F - K B plays a major 
role in the induction of iNOS [27]. Thus, N F - K B , which is 
involved in the regulation of IL-1, IL-6, and TNF-oc could 
also represent a potential transcriptional modulator of iNOS 
in the myocardium. 
The third key observation of our study is the detection of 
increased AP-1 levels in the postischemic myocardium. AP-1 
was not detected in the controls (sham-operated) and its levels 
increased in a monophasic manner. In contrast to N F - K B 
where a second peak was observed at 3 h R, AP-1 levels 
declined gradually after an initial increase at 15 min of reper-
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fusion. Though we did not measure the levels of AP-1 during 
the ischemic period, in various in vitro systems, substantial 
increase in AP-1 levels was demonstrated during hypoxic con-
ditions. In a cancerous cell line (HeLa), Rupee and Baeuerle 
have shown increased N F - K B activity within 15 min after in-
itiation of reperfusion, while increased AP-1 was detected dur-
ing hypoxia itself [28]. Further, levels of AP-1 increased in a 
biphasic manner during reoxygenation. They argued that dur-
ing reoxygenation, increased intracellular ROI activate ex-
isting N F - K B by dissociation from its inhibitor IKB, while 
low levels of free radicals during hypoxia, a condition simi-
lar to that observed during antioxidant treatment, induced 
AP-1. Though AP-1 is induced during both prooxidant and 
antioxidant conditions, they speculated that AP-1 induced 
during prooxidant status may have weak DNA binding 
and weak transactivating potential, and during antioxidant 
status, it will have full DNA-binding and full transactivat-
ing potential [28]. However, more studies are needed to eluci-
date the precise roles of these factors in postischemic myocar-
dium. 
Because both N F - K B and AP-1 are activated by cytokines 
such as IL-1 and TNF-oc, the positive synergy between N F - K B 
and the subunits of AP-1 might have important implications 
for both immune and inflammatory responses. Stein et al. 
have shown functional cross-coupling of N F - K B p65 and 
AP-1 families of transcription factors, resulting in increased 
DNA binding activity of N F - K B [29]. Both c-fos and c-jun 
synergised with N F - K B by physically interacting with p65 sub-
unit [29]. Whether such interactions exist in reperfused myo-
cardium is not known. In conclusion, we have shown a bi-
phasic increase in levels of N F - K B and a monophasic increase 
in AP-1 in the postischemic myocardium. Of the two subunits 
of N F - K B , p65 appears to play the dominant role, while p50 
levels were consistent over time. This raises the interesting 
possibility that N F - K B may serve as an important regulator 
of transcriptional events during I/R. This factor may partici-
pate in the rapid production of inflammatory cytokines (IL-1, 
IL-6, TNF-a, iNOS) during reperfusion, and may contribute 
to the reversible loss in function and tissue damage during the 
postischemic period. While more studies are needed to clarify 
the role of AP-1 during ischemia/reperfusion, interference 
with the activation or the activity of N F - K B may prove to 
be beneficial in suppressing or minimizing some of the dele-
terious effects observed following reperfusion of ischemic tis-
sue. 
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